2021 Q2 Form 10-Q Financial Statement

#000112737121000128 Filed on August 04, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2 2020 Q1
Revenue $18.36M $15.98M $16.51M
YoY Change 14.83% -4.74% 1.33%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.200M $1.410M $1.180M
YoY Change 56.03% -18.97% -36.56%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $274.0K $410.0K $477.0K
YoY Change -33.17% -50.84% 5.07%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $10.03M $3.121M $9.117M
YoY Change 221.31% -63.16% 27.17%
Income Tax $2.465M $820.0K $2.494M
% Of Pretax Income 24.58% 26.27% 27.36%
Net Earnings $7.563M $2.301M $6.623M
YoY Change 228.68% -62.2% 26.97%
Net Earnings / Revenue 41.2% 14.4% 40.12%
Basic Earnings Per Share $0.61 $0.18 $0.52
Diluted Earnings Per Share $0.60 $0.18 $0.52
COMMON SHARES
Basic Shares Outstanding 12.50M shares 12.45M shares 12.73M shares
Diluted Shares Outstanding 12.55M shares 12.49M shares 12.78M shares

Balance Sheet

Concept 2021 Q2 2020 Q2 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $120.7M $118.6M $36.16M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $8.465M $7.257M $7.410M
YoY Change 16.65% -6.26% -8.47%
Goodwill $53.78M $53.78M $53.78M
YoY Change 0.0% 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $2.281B $1.914B $1.619B
YoY Change 19.17% 18.63% 3.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $45.30M $30.50M $44.20M
YoY Change 48.52% 7.77% 37.69%
Accrued Expenses $5.900M $6.100M
YoY Change -13.24% -24.69%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $45.30M $30.50M $44.20M
YoY Change 48.52% 7.77% 37.69%
LONG-TERM LIABILITIES
Long-Term Debt $5.200M $5.200M $5.200M
YoY Change 0.0% 0.0% 0.0%
Other Long-Term Liabilities $13.00M $10.60M $9.300M
YoY Change 22.64% 8.16% -10.58%
Total Long-Term Liabilities $5.200M $5.200M $5.200M
YoY Change 0.0% 0.0% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $45.30M $30.50M $44.20M
Total Long-Term Liabilities $5.200M $5.200M $5.200M
Total Liabilities $2.030B $1.685B $1.400B
YoY Change 20.43% 21.98% 4.73%
SHAREHOLDERS EQUITY
Retained Earnings $162.9M $142.1M $141.1M
YoY Change 14.66% 10.37% 13.7%
Common Stock $75.27M $79.06M $78.85M
YoY Change -4.8% -19.5% -22.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $251.0M $228.6M $218.7M
YoY Change
Total Liabilities & Shareholders Equity $2.281B $1.914B $1.619B
YoY Change 19.17% 18.63% 3.48%

Cashflow Statement

Concept 2021 Q2 2020 Q2 2020 Q1
OPERATING ACTIVITIES
Net Income $7.563M $2.301M $6.623M
YoY Change 228.68% -62.2% 26.97%
Depreciation, Depletion And Amortization $2.200M $1.410M $1.180M
YoY Change 56.03% -18.97% -36.56%
Cash From Operating Activities $21.40M -$4.160M $5.931M
YoY Change -614.42% -249.64% -14.07%
INVESTING ACTIVITIES
Capital Expenditures -$360.0K -$70.00K $32.00K
YoY Change 414.29% -58.82% -75.94%
Acquisitions
YoY Change
Other Investing Activities -$165.8M -$211.1M -$27.42M
YoY Change -21.43% 629.77% 162.14%
Cash From Investing Activities -$166.2M -$211.1M -$27.45M
YoY Change -21.29% 625.75% 159.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $11.05M
YoY Change 489.75%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 50.61M 297.7M $5.111M
YoY Change -83.0% 597.45% 21.84%
NET CHANGE
Cash From Operating Activities 21.40M -4.160M $5.931M
Cash From Investing Activities -166.2M -211.1M -$27.45M
Cash From Financing Activities 50.61M 297.7M $5.111M
Net Change In Cash -94.17M 82.39M -$16.41M
YoY Change -214.3% 403.3% -3330.71%
FREE CASH FLOW
Cash From Operating Activities $21.40M -$4.160M $5.931M
Capital Expenditures -$360.0K -$70.00K $32.00K
Free Cash Flow $21.76M -$4.090M $5.899M
YoY Change -632.03% -238.64% -12.85%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001127371
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
10439000 USD
CY2020Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
12915000 USD
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12524609 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12509848 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12329089 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12509848 shares
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2021Q2 cvcy Financing Receivable Modifications Subsequent Defaults During Period Number Of Contracts
FinancingReceivableModificationsSubsequentDefaultsDuringPeriodNumberOfContracts
0 contract
CY2020Q2 cvcy Financing Receivable Modifications Subsequent Defaults During Period Number Of Contracts
FinancingReceivableModificationsSubsequentDefaultsDuringPeriodNumberOfContracts
0 contract
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-31977
dei Entity Registrant Name
EntityRegistrantName
CENTRAL VALLEY COMMUNITY BANCORP
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
CA
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
77-0539125
dei Entity Address Address Line1
EntityAddressAddressLine1
7100 N. Financial Dr., Suite 101
dei Entity Address City Or Town
EntityAddressCityOrTown
Fresno
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
93720
dei City Area Code
CityAreaCode
559
dei Local Phone Number
LocalPhoneNumber
298-1775
dei Security12b Title
Security12bTitle
Common Stock, no par value
dei Trading Symbol
TradingSymbol
CVCY
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
11984214 shares
CY2021Q2 us-gaap Cash And Due From Banks
CashAndDueFromBanks
39346000 USD
CY2020Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
34175000 USD
CY2021Q2 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
81320000 USD
CY2020Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
36103000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
120666000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
70278000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
952416000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
710092000 USD
CY2021Q2 us-gaap Available For Sale Securities Equity Securities
AvailableForSaleSecuritiesEquitySecurities
7522000 USD
CY2020Q4 us-gaap Available For Sale Securities Equity Securities
AvailableForSaleSecuritiesEquitySecurities
7634000 USD
CY2021Q2 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
1059506000 USD
CY2020Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
1089432000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8465000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8228000 USD
CY2021Q2 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
39062000 USD
CY2020Q4 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
28713000 USD
CY2021Q2 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
5595000 USD
CY2020Q4 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
5595000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
53777000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
53777000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
835000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1183000 USD
CY2021Q2 cvcy Accrued Interest Receivable And Other Assets
AccruedInterestReceivableAndOtherAssets
32706000 USD
CY2020Q4 cvcy Accrued Interest Receivable And Other Assets
AccruedInterestReceivableAndOtherAssets
29164000 USD
CY2021Q2 us-gaap Assets
Assets
2280550000 USD
CY2020Q4 us-gaap Assets
Assets
2004096000 USD
CY2021Q2 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
899406000 USD
CY2020Q4 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
824889000 USD
CY2021Q2 us-gaap Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
1079688000 USD
CY2020Q4 us-gaap Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
897821000 USD
CY2021Q2 us-gaap Deposits
Deposits
1979094000 USD
CY2020Q4 us-gaap Deposits
Deposits
1722710000 USD
CY2021Q2 us-gaap Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust
JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust
5155000 USD
CY2020Q4 us-gaap Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust
JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust
5155000 USD
CY2021Q2 cvcy Accrued Interest Payable And Other Liabilities
AccruedInterestPayableAndOtherLiabilities
45252000 USD
CY2020Q4 cvcy Accrued Interest Payable And Other Liabilities
AccruedInterestPayableAndOtherLiabilities
31210000 USD
CY2021Q2 us-gaap Liabilities
Liabilities
2029501000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
1759075000 USD
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
75265000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
79416000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
162910000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
150749000 USD
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
12874000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
14856000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
251049000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
245021000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2280550000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2004096000 USD
CY2021Q2 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
13556000 USD
CY2020Q2 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
12600000 USD
us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
27321000 USD
us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
25498000 USD
CY2021Q2 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
29000 USD
CY2020Q2 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
13000 USD
us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
61000 USD
us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
196000 USD
CY2021Q2 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
3361000 USD
CY2020Q2 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
2959000 USD
us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
6094000 USD
us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
6225000 USD
CY2021Q2 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
1409000 USD
CY2020Q2 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
412000 USD
CY2021Q2 us-gaap Interest Expense Domestic Deposits
InterestExpenseDomesticDeposits
252000 USD
CY2020Q2 us-gaap Interest Expense Domestic Deposits
InterestExpenseDomesticDeposits
374000 USD
us-gaap Interest Expense Domestic Deposits
InterestExpenseDomesticDeposits
520000 USD
us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
2726000 USD
us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
571000 USD
CY2021Q2 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
18355000 USD
CY2020Q2 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
15984000 USD
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
36202000 USD
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
32490000 USD
us-gaap Interest Expense Domestic Deposits
InterestExpenseDomesticDeposits
806000 USD
CY2021Q2 us-gaap Interest Expense Junior Subordinated Debentures
InterestExpenseJuniorSubordinatedDebentures
22000 USD
CY2020Q2 us-gaap Interest Expense Junior Subordinated Debentures
InterestExpenseJuniorSubordinatedDebentures
36000 USD
us-gaap Interest Expense Junior Subordinated Debentures
InterestExpenseJuniorSubordinatedDebentures
46000 USD
us-gaap Interest Expense Junior Subordinated Debentures
InterestExpenseJuniorSubordinatedDebentures
81000 USD
CY2021Q2 us-gaap Interest Expense
InterestExpense
274000 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
410000 USD
us-gaap Interest Expense
InterestExpense
566000 USD
us-gaap Interest Expense
InterestExpense
887000 USD
CY2021Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
18081000 USD
CY2020Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
15574000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
35636000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
31603000 USD
CY2021Q2 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
-1500000 USD
CY2020Q2 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
3000000 USD
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
-3300000 USD
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
4375000 USD
CY2021Q2 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
19581000 USD
CY2020Q2 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
12574000 USD
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
38936000 USD
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
27228000 USD
CY2021Q2 cvcy Service Charges
ServiceCharges
467000 USD
CY2020Q2 cvcy Service Charges
ServiceCharges
447000 USD
cvcy Service Charges
ServiceCharges
899000 USD
cvcy Service Charges
ServiceCharges
1093000 USD
CY2021Q2 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
176000 USD
CY2020Q2 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
176000 USD
us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
349000 USD
us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
358000 USD
CY2021Q2 cvcy Interchange Fees
InterchangeFees
471000 USD
CY2020Q2 cvcy Interchange Fees
InterchangeFees
307000 USD
cvcy Interchange Fees
InterchangeFees
841000 USD
cvcy Interchange Fees
InterchangeFees
640000 USD
CY2021Q2 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
-79000 USD
CY2020Q2 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
-58000 USD
us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
-79000 USD
us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
4140000 USD
CY2021Q2 cvcy Dividends Federal Home Loan Bank Stocks
DividendsFederalHomeLoanBankStocks
83000 USD
CY2020Q2 cvcy Dividends Federal Home Loan Bank Stocks
DividendsFederalHomeLoanBankStocks
75000 USD
cvcy Dividends Federal Home Loan Bank Stocks
DividendsFederalHomeLoanBankStocks
153000 USD
cvcy Dividends Federal Home Loan Bank Stocks
DividendsFederalHomeLoanBankStocks
182000 USD
CY2021Q2 cvcy Loan Placement Fees
LoanPlacementFees
510000 USD
CY2020Q2 cvcy Loan Placement Fees
LoanPlacementFees
561000 USD
cvcy Loan Placement Fees
LoanPlacementFees
1167000 USD
cvcy Loan Placement Fees
LoanPlacementFees
860000 USD
CY2021Q2 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
449000 USD
CY2020Q2 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
537000 USD
us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
746000 USD
us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
1315000 USD
CY2021Q2 us-gaap Noninterest Income
NoninterestIncome
2077000 USD
CY2020Q2 us-gaap Noninterest Income
NoninterestIncome
2045000 USD
us-gaap Noninterest Income
NoninterestIncome
4076000 USD
us-gaap Noninterest Income
NoninterestIncome
8588000 USD
CY2021Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
6979000 USD
CY2020Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
6812000 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
13917000 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
14324000 USD
CY2021Q2 us-gaap Occupancy Net
OccupancyNet
1201000 USD
CY2020Q2 us-gaap Occupancy Net
OccupancyNet
1139000 USD
us-gaap Occupancy Net
OccupancyNet
2314000 USD
us-gaap Occupancy Net
OccupancyNet
2283000 USD
CY2021Q2 us-gaap Professional Fees
ProfessionalFees
475000 USD
CY2020Q2 us-gaap Professional Fees
ProfessionalFees
522000 USD
us-gaap Professional Fees
ProfessionalFees
831000 USD
us-gaap Professional Fees
ProfessionalFees
980000 USD
CY2021Q2 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
625000 USD
CY2020Q2 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
554000 USD
us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
1242000 USD
us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
890000 USD
CY2021Q2 cvcy Regulatory Assessments
RegulatoryAssessments
172000 USD
CY2020Q2 cvcy Regulatory Assessments
RegulatoryAssessments
146000 USD
cvcy Regulatory Assessments
RegulatoryAssessments
333000 USD
cvcy Regulatory Assessments
RegulatoryAssessments
193000 USD
CY2021Q2 cvcy At Mand Debit Card Expenses
ATMandDebitCardExpenses
191000 USD
CY2020Q2 cvcy At Mand Debit Card Expenses
ATMandDebitCardExpenses
187000 USD
cvcy At Mand Debit Card Expenses
ATMandDebitCardExpenses
416000 USD
cvcy At Mand Debit Card Expenses
ATMandDebitCardExpenses
481000 USD
CY2021Q2 cvcy Information Technology
InformationTechnology
611000 USD
CY2020Q2 cvcy Information Technology
InformationTechnology
602000 USD
cvcy Information Technology
InformationTechnology
1170000 USD
cvcy Information Technology
InformationTechnology
1210000 USD
CY2021Q2 cvcy Directors Expenses
DirectorsExpenses
113000 USD
CY2020Q2 cvcy Directors Expenses
DirectorsExpenses
136000 USD
cvcy Directors Expenses
DirectorsExpenses
154000 USD
cvcy Directors Expenses
DirectorsExpenses
328000 USD
CY2021Q2 us-gaap Advertising Expense
AdvertisingExpense
128000 USD
CY2020Q2 us-gaap Advertising Expense
AdvertisingExpense
167000 USD
us-gaap Advertising Expense
AdvertisingExpense
257000 USD
us-gaap Advertising Expense
AdvertisingExpense
340000 USD
CY2021Q2 cvcy Internet Banking Expense
InternetBankingExpense
84000 USD
CY2020Q2 cvcy Internet Banking Expense
InternetBankingExpense
182000 USD
cvcy Internet Banking Expense
InternetBankingExpense
208000 USD
cvcy Internet Banking Expense
InternetBankingExpense
378000 USD
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
173000 USD
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
173000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
347000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
347000 USD
CY2021Q2 us-gaap Other Noninterest Expense
OtherNoninterestExpense
878000 USD
CY2020Q2 us-gaap Other Noninterest Expense
OtherNoninterestExpense
878000 USD
us-gaap Other Noninterest Expense
OtherNoninterestExpense
1829000 USD
us-gaap Other Noninterest Expense
OtherNoninterestExpense
1823000 USD
CY2021Q2 us-gaap Noninterest Expense
NoninterestExpense
11630000 USD
CY2020Q2 us-gaap Noninterest Expense
NoninterestExpense
11498000 USD
us-gaap Noninterest Expense
NoninterestExpense
23018000 USD
us-gaap Noninterest Expense
NoninterestExpense
23577000 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
10028000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3121000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
19994000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
12239000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2465000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
820000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4952000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3315000 USD
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
7563000 USD
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2301000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
15042000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
8924000 USD
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.61
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.20
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.71
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12498809 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12449283 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12497217 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12592126 shares
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.60
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.20
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.71
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12548044 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12486681 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12548101 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12646403 shares
CY2021Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.12
CY2020Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.11
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.23
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.22
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
7563000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
2301000 USD
us-gaap Net Income Loss
NetIncomeLoss
15042000 USD
us-gaap Net Income Loss
NetIncomeLoss
8924000 USD
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
10729000 USD
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
12366000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-2892000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
10808000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
12424000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
10679000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
-79000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
-58000 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
-79000 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
4140000 USD
us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-2813000 USD
us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
6539000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
3196000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
3673000 USD
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-831000 USD
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
1933000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
7612000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
8751000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1982000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4606000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
15175000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
11052000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
13060000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
13530000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
218673000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
2301000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
8751000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2020Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
58000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
128000 USD
CY2020Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1372000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
19000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
228558000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
241845000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
7563000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
7612000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
54000 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
109000 USD
CY2021Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1504000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
212000 USD
CY2021Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
4842000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
251049000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
228128000 USD
us-gaap Net Income Loss
NetIncomeLoss
8924000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
4606000 USD
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
115000 USD
us-gaap Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
141000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
248000 USD
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2780000 USD
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
11052000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
228000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
228558000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
245021000 USD
us-gaap Net Income Loss
NetIncomeLoss
15042000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-1982000 USD
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
110000 USD
us-gaap Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
158000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
210000 USD
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2881000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
213000 USD
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
4842000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
251049000 USD
us-gaap Net Income Loss
NetIncomeLoss
15042000 USD
us-gaap Net Income Loss
NetIncomeLoss
8924000 USD
cvcy Decrease Deferred Loan Costs
DecreaseDeferredLoanCosts
-1222000 USD
cvcy Decrease Deferred Loan Costs
DecreaseDeferredLoanCosts
5975000 USD
us-gaap Depreciation Nonproduction
DepreciationNonproduction
467000 USD
us-gaap Depreciation Nonproduction
DepreciationNonproduction
462000 USD
cvcy Accretion Amortizationof Discountsand Premiums
AccretionAmortizationofDiscountsandPremiums
693000 USD
cvcy Accretion Amortizationof Discountsand Premiums
AccretionAmortizationofDiscountsandPremiums
666000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
3578000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
2128000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
210000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
248000 USD
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
-3300000 USD
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
4375000 USD
us-gaap Availableforsale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments
AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments
-79000 USD
us-gaap Availableforsale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments
AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments
4140000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
8000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
6000 USD
us-gaap Increase Decrease In Trading Securities
IncreaseDecreaseInTradingSecurities
-112000 USD
us-gaap Increase Decrease In Trading Securities
IncreaseDecreaseInTradingSecurities
183000 USD
us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
349000 USD
us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
198000 USD
cvcy Gain Loss On Bank Owned Life Insurance
GainLossOnBankOwnedLifeInsurance
0 USD
cvcy Gain Loss On Bank Owned Life Insurance
GainLossOnBankOwnedLifeInsurance
462000 USD
cvcy Increase Decrease In Accrued Interest Receivable And Other Operating Assets Net
IncreaseDecreaseInAccruedInterestReceivableAndOtherOperatingAssetsNet
3767000 USD
cvcy Increase Decrease In Accrued Interest Receivable And Other Operating Assets Net
IncreaseDecreaseInAccruedInterestReceivableAndOtherOperatingAssetsNet
1418000 USD
cvcy Increase Decrease In Interest Payable And Other Operating Liabilities Net
IncreaseDecreaseInInterestPayableAndOtherOperatingLiabilitiesNet
14199000 USD
cvcy Increase Decrease In Interest Payable And Other Operating Liabilities Net
IncreaseDecreaseInInterestPayableAndOtherOperatingLiabilitiesNet
417000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-983000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
1735000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
27775000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1771000 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
271930000 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
202390000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
590000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
122151000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
23660000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
16103000 USD
us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
-32004000 USD
us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
176105000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
704000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
101000 USD
us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
10000000 USD
us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
250000 USD
us-gaap Payments For Proceeds From Federal Home Loan Bank Stock
PaymentsForProceedsFromFederalHomeLoanBankStock
0 USD
us-gaap Payments For Proceeds From Federal Home Loan Bank Stock
PaymentsForProceedsFromFederalHomeLoanBankStock
-467000 USD
us-gaap Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
0 USD
us-gaap Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
1550000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
9000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
6000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-226371000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-238569000 USD
cvcy Net Increase Decrease In Demand Interest Bearing And Savings Deposits
NetIncreaseDecreaseInDemandInterestBearingAndSavingsDeposits
256426000 USD
cvcy Net Increase Decrease In Demand Interest Bearing And Savings Deposits
NetIncreaseDecreaseInDemandInterestBearingAndSavingsDeposits
319263000 USD
us-gaap Increase Decrease In Time Deposits
IncreaseDecreaseInTimeDeposits
-42000 USD
us-gaap Increase Decrease In Time Deposits
IncreaseDecreaseInTimeDeposits
-2993000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4842000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
11052000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
110000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
115000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
213000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
228000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
2881000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
2780000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
248984000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
302781000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
50388000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
65983000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
70278000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
52574000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
120666000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
118557000 USD
us-gaap Interest Paid Net
InterestPaidNet
576000 USD
us-gaap Interest Paid Net
InterestPaidNet
937000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
6105000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2810000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
1124000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
1120000 USD
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
No customer accounts for more than 10 percent of revenues for the Company or the Bank.
CY2021Q2 us-gaap Pledged Assets Separately Reported Securities Pledged As Collateral At Fair Value
PledgedAssetsSeparatelyReportedSecuritiesPledgedAsCollateralAtFairValue
191882000 USD
CY2021Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainLossBeforeTax
18278000 USD
CY2020Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainLossBeforeTax
21091000 USD
CY2021Q2 cvcy Accumulated Other Comprehensive Income Available For Sale Securities Adjustment Tax
AccumulatedOtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentTax
5404000000 USD
CY2020Q4 cvcy Accumulated Other Comprehensive Income Available For Sale Securities Adjustment Tax
AccumulatedOtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentTax
6235000 USD
CY2021Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
934138000 USD
CY2021Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
22780000 USD
CY2021Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
4502000 USD
CY2021Q2 us-gaap Available For Sale Securities
AvailableForSaleSecurities
952416000 USD
CY2020Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
689001000 USD
CY2020Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
23371000 USD
CY2020Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
2280000 USD
CY2020Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
710092000 USD
CY2021Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
4037000 USD
CY2021Q2 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
590000 USD
CY2020Q2 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
16114000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
590000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
122151000 USD
CY2021Q2 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
0 USD
CY2020Q2 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
306000 USD
us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
0 USD
us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
4504000 USD
CY2021Q2 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
79000 USD
CY2020Q2 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
364000 USD
us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
79000 USD
us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
364000 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
1224000 USD
CY2021Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
245156000 USD
CY2021Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
57021000 USD
CY2021Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
465000 USD
CY2021Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
302177000 USD
CY2021Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
4502000 USD
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
105252000 USD
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
1085000 USD
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
81237000 USD
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
1195000 USD
CY2020Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
186489000 USD
CY2020Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
2280000 USD
cvcy Threshold Period Of Value Decline In Available For Sale Securities To Be Considered Other Than Temporary Impairment
ThresholdPeriodOfValueDeclineInAvailableForSaleSecuritiesToBeConsideredOtherThanTemporaryImpairment
P12M
cvcy Threshold Percentage Of Value Decline In Available For Sale Securities To Be Considered Other Than Temporary Impairment
ThresholdPercentageOfValueDeclineInAvailableForSaleSecuritiesToBeConsideredOtherThanTemporaryImpairment
0.10
cvcy Threshold Amount Of Value Decline In Available For Sale Securities To Be Considered Other Than Temporary Impairment
ThresholdAmountOfValueDeclineInAvailableForSaleSecuritiesToBeConsideredOtherThanTemporaryImpairment
75000 USD
us-gaap Impairment Of Investments
ImpairmentOfInvestments
0 USD
CY2021Q2 cvcy Available For Sale Securities Number Of Securities Loss Position
AvailableForSaleSecuritiesNumberOfSecuritiesLossPosition
5 Loans
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
304000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
305000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
3317000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
3627000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
84162000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
86564000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
390454000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
403156000 USD
CY2021Q2 cvcy Available For Sale Securities Debt Maturities With Single Maturity Date Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesWithSingleMaturityDateAmortizedCostBasis
478237000 USD
CY2021Q2 cvcy Available For Sale Securities Debt Maturities With Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithSingleMaturityDateFairValue
493652000 USD
CY2021Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
934138000 USD
CY2021Q2 us-gaap Available For Sale Securities
AvailableForSaleSecurities
952416000 USD
CY2021Q2 us-gaap Unamortized Loan Commitment And Origination Fees And Unamortized Discounts Or Premiums
UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums
-1390000 USD
CY2020Q4 us-gaap Unamortized Loan Commitment And Origination Fees And Unamortized Discounts Or Premiums
UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums
-2612000 USD
CY2021Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
1069945000 USD
CY2021Q2 cvcy Loans And Leases Receivable Percentage Of Gross Loans
LoansAndLeasesReceivablePercentageOfGrossLoans
1.000
CY2020Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
1102347000 USD
CY2020Q4 cvcy Loans And Leases Receivable Percentage Of Gross Loans
LoansAndLeasesReceivablePercentageOfGrossLoans
1.000
CY2021Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
10439000 USD
CY2020Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
12915000 USD
CY2021Q2 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
1059506000 USD
CY2020Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
1089432000 USD
CY2021Q2 cvcy Loansand Leases Receivable Allowance Numberof Components
LoansandLeasesReceivableAllowanceNumberofComponents
2 component
CY2021Q2 cvcy Financing Receivable Allowance For Credit Losses Methodology Change Number Of Rolling Quarters Used In Analysis
FinancingReceivableAllowanceForCreditLossesMethodologyChangeNumberOfRollingQuartersUsedInAnalysis
50 quarter
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
12056000 USD
CY2021Q2 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
1500000 USD
CY2021Q2 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
171000 USD
CY2021Q2 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
54000 USD
CY2021Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
10439000 USD
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
10546000 USD
CY2020Q2 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
3000000 USD
CY2020Q2 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
80000 USD
CY2020Q2 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
471000 USD
CY2020Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
13937000 USD
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
12915000 USD
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
3300000 USD
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
228000 USD
us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
1052000 USD
CY2021Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
10439000 USD
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
9130000 USD
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
-4375000 USD
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
123000 USD
us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
555000 USD
CY2020Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
13937000 USD
CY2021Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
10439000 USD
CY2021Q2 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
880000 USD
CY2021Q2 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
9559000 USD
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
12915000 USD
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
631000 USD
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
12284000 USD
CY2021Q2 us-gaap Notes Receivable Gross
NotesReceivableGross
1071335000 USD
CY2021Q2 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
8539000 USD
CY2021Q2 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
1062796000 USD
CY2020Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
1104959000 USD
CY2020Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
11186000 USD
CY2020Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
1093773000 USD
CY2021Q2 us-gaap Notes Receivable Gross
NotesReceivableGross
1071335000 USD
CY2020Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
1104959000 USD
CY2021Q2 us-gaap Notes Receivable Gross
NotesReceivableGross
1071335000 USD
CY2021Q2 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
0 USD
CY2021Q2 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
2035000 USD
CY2020Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
1104959000 USD
CY2020Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
0 USD
CY2020Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
3278000 USD
CY2021Q2 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
939000 USD
CY2021Q2 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
1036000 USD
CY2021Q2 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
7600000 USD
CY2021Q2 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
7674000 USD
CY2021Q2 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
880000 USD
CY2021Q2 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
8539000 USD
CY2021Q2 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
8710000 USD
CY2021Q2 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
880000 USD
CY2020Q4 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
1114000 USD
CY2021Q2 us-gaap Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans
LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans
34000 USD
CY2020Q4 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
1239000 USD
CY2020Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
10072000 USD
CY2020Q4 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
10132000 USD
CY2020Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
631000 USD
CY2020Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
11186000 USD
CY2020Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
11371000 USD
CY2020Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
631000 USD
CY2021Q2 us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
965000 USD
CY2021Q2 us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
8000 USD
CY2020Q2 us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
1899000 USD
CY2020Q2 us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
3000 USD
CY2021Q2 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
9007000 USD
CY2021Q2 us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
84000 USD
CY2020Q2 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
13584000 USD
CY2020Q2 us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
200000 USD
us-gaap Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans
LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans
74000 USD
CY2021Q2 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
9972000 USD
CY2021Q2 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
92000 USD
CY2020Q2 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
15483000 USD
CY2020Q2 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
203000 USD
us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
953000 USD
us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
17000 USD
us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
2050000 USD
us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
6000 USD
us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
9652000 USD
us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
186000 USD
us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
8353000 USD
us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
402000 USD
us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
10605000 USD
us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
203000 USD
us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
10403000 USD
us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
408000 USD
us-gaap Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans
LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans
72000 USD
cvcy Financing Receivable Modifications Subsequent Defaults During Period Number Of Contracts
FinancingReceivableModificationsSubsequentDefaultsDuringPeriodNumberOfContracts
0 contract
cvcy Financing Receivable Modifications Subsequent Defaults During Period Number Of Contracts
FinancingReceivableModificationsSubsequentDefaultsDuringPeriodNumberOfContracts
0 contract
CY2020Q3 us-gaap Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans
LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans
55000 USD
CY2021Q2 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
6504000 USD
CY2020Q4 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
7908000 USD
CY2021Q2 cvcy Financing Receivable Modifications Related Allowance
FinancingReceivableModificationsRelatedAllowance
515000 USD
CY2020Q4 cvcy Financing Receivable Modifications Related Allowance
FinancingReceivableModificationsRelatedAllowance
20000 USD
CY2021Q2 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
1 Loans
CY2021Q2 us-gaap Goodwill
Goodwill
53777000 USD
CY2020Q4 us-gaap Federal Funds Purchased
FederalFundsPurchased
0 USD
CY2021Q2 us-gaap Federal Funds Purchased
FederalFundsPurchased
0 USD
CY2021Q2 us-gaap Other Commitment
OtherCommitment
2475000 USD
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
7563000 USD
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2301000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
15042000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
8924000 USD
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12498809 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12449283 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12497217 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12592126 shares
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.61
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.20
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.71
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
7563000 USD
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2301000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
15042000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
8924000 USD
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12498809 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12449283 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12497217 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12592126 shares
CY2021Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
49235 shares
CY2020Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
37398 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
50884 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
54277 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12548044 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12486681 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12548101 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12646403 shares
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.60
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.20
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.71
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2021Q2 cvcy Sharebased Compensation Arrangementby Sharebased Payment Award Numberof Plans
SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofPlans
4 plan
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
210000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
248000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
77070 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.06
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
20000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
10.63
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
57070 shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.86
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y21D
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
587000 USD
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
57070 shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
9.86
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P1Y21D
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
587000 USD
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
57070 shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
9.86
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P1Y21D
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
587000 USD
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
204000 USD
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
32000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
206000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
381000 USD
CY2021Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
212000 USD
CY2020Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
19000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
213000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
228000 USD
CY2021Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
46000 USD
CY2020Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
0 USD
us-gaap Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
46000 USD
us-gaap Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
72000 USD
CY2021Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
0 USD
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.61
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.60
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
CY2021Q2 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
-1500000 USD
CY2020Q2 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
3000000 USD
CY2021Q2 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
13556000 USD
CY2020Q2 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
12600000 USD
CY2021Q2 us-gaap Interest Expense Domestic Deposits
InterestExpenseDomesticDeposits
252000 USD
CY2020Q2 us-gaap Interest Expense Domestic Deposits
InterestExpenseDomesticDeposits
374000 USD
CY2021Q2 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
-1500000 USD
CY2020Q2 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
3000000 USD
CY2021Q2 cvcy Service Charges
ServiceCharges
467000 USD
CY2020Q2 cvcy Service Charges
ServiceCharges
447000 USD
CY2021Q2 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
449000 USD
CY2020Q2 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
537000 USD
CY2021Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
6979000 USD
CY2020Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
6812000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2465000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
820000 USD

Files In Submission

Name View Source Status
0001127371-21-000128-index-headers.html Edgar Link pending
0001127371-21-000128-index.html Edgar Link pending
0001127371-21-000128.txt Edgar Link pending
0001127371-21-000128-xbrl.zip Edgar Link pending
cvcy-20210630.htm Edgar Link pending
cvcy-20210630.xsd Edgar Link pending
cvcy-20210630_cal.xml Edgar Link unprocessable
cvcy-20210630_def.xml Edgar Link unprocessable
cvcy-20210630_htm.xml Edgar Link completed
cvcy-20210630_lab.xml Edgar Link unprocessable
cvcy-20210630_pre.xml Edgar Link unprocessable
exhibit1093salarycontinuat.htm Edgar Link pending
exhibit1094splitdollarluis.htm Edgar Link pending
exhibit3112021q2-ng.htm Edgar Link pending
exhibit3122021q2-ng.htm Edgar Link pending
exhibit3212021q2-ng.htm Edgar Link pending
exhibit3222021q2-ng.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending